1446 Federal Register / Vol. 76, No. 6 / Monday, January 10, 2011 / Notices 

Date: February 7–8, 2011. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Doubletree Guest Suites Hotel at 

Doheny Beach, 34402 Pacific Coast Highway, 

Dana Point, CA 92629. 

Contact Person: Behrouz Shabestari, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5106, 

MSC 7854, Bethesda, MD 20892. (301) 435– 

2409. shabestb@csr.nih.gov. 

Name of Committee: Surgical Sciences, 

Biomedical Imaging and Bioengineering 

Integrated Review Group, Bioengineering, 

Technology and Surgical Sciences Study 

Section. 

Date: February 7–8, 2011. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hyatt Regency Bethesda, One 

Bethesda Metro Center, 7400 Wisconsin 

Avenue, Bethesda, MD 20814. 

Contact Person: Khalid Masood, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5120, 

MSC 7854, Bethesda, MD 20892. 301–435– 

2392. masoodk@csr.nih.gov. 

Name of Committee: Biology of 

Development and Aging Integrated Review 

Group, Aging Systems and Geriatrics Study 

Section. 

Date: February 7–8, 2011. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Sheraton Delfina Santa Monica 

Hotel, 530 West Pico Boulevard, Santa 

Monica, CA 90405. 

Contact Person: James P. Harwood, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5168, 

MSC 7840, Bethesda, MD 20892. 301–435– 

1256. harwoodj@csr.nih.gov. 

Name of Committee: Surgical Sciences, 

Biomedical Imaging and Bioengineering 

Integrated Review Group, Clinical Molecular 

Imaging and Probe Development. 

Date: February 7–8, 2011. 

Agenda: 2 p.m. to 12 p.m. 

Place: To review and evaluate grant 

applications. 

Contact Person: Doubletree Guest Suites 

Hotel at Doheny Beach, 34402 Pacific Coast 

Highway, Dana Point, CA 92629. Eileen W. 

Bradley, DSC, Scientific Review Officer, 

Center for Scientific Review, National 

Institutes of Health, 6701 Rockledge Drive, 

Room 5100, MSC 7854, Bethesda, MD 20892. 

(301) 435–1179. bradleye@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Review of 

NCRR Resource Southwestern NMR Center 

for In Vivo Metabolism. 

Date: February 7–9, 2011. 

Time: 6 p.m. to 12 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hilton Garden Inn Dallas Market 

Center, 2325 North Stemmons Freeway, 

Dallas, TX 75207. 

Contact Person: Antonio Sastre, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5215, 

MSC 7412, Bethesda, MD 20892. 301–435– 

2592. sastrea@csr.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Progra.m. Nos. 93.306, Comparative 

Medicine; 93.333, Clinical Research, 93.306, 

93.333, 93.337, 93.393–93.396, 93.837– 

93.844, 93.846–93.878, 93.892, 93.893, 

National Institutes of Health, HHS) 

Dated: January 4, 2011. 

Anna P. Snouffer, 

Deputy Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2011–257 Filed 1–7–11; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Amended 

Notice of Meeting 

Notice is hereby given of a change in 

the meeting of the Center for Scientific 

Review Special Emphasis Panel, January 

10, 2011, 8 a.m. to January 11, 2011, 5 

p.m., National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

which was published in the Federal 

Register on December 22, 2010, 75 FR 

80508. 

The starting time of the meeting on 

January 10, 2011 has been changed to 11 

a.m. until adjournment on January 11, 

2011. The meeting is closed to the 

public. 

Dated: January 4, 2011. 

Anna P. Snouffer, 

Deputy Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2011–255 Filed 1–7–11; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Cancer 

Institute Initial Review Group; Subcommittee 

F—Manpower & Training. To review and 

evaluate grant applications. 

Date: February 22–23, 2011. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hilton Alexandria Old Town, 1767 

King Street, Alexandria, VA 22314. 

Contact Person: Lynn M. Amende, PhD, 

Scientific Review Officer, Resources And 

Training Review Branch, Division of 

Extramural Activities, National Cancer 

Institute, NIH, 6116 Executive Blvd., Room 

8105, Bethesda, MD 20892, 301–451–4759, 

amendel@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.392, Cancer Construction; 

93.393, Cancer Cause and Prevention 

Research; 93.394, Cancer Detection and 

Diagnosis Research; 93.395, Cancer 

Treatment Research; 93.396, Cancer Biology 

Research; 93.397, Cancer Centers Support; 

93.398, Cancer Research Manpower; 93.399, 

Cancer Control, National Institutes of Health, 

HHS) 

Dated: January 4, 2011. 

Jennifer S. Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2011–253 Filed 1–7–11; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Substance Abuse and Mental Health 

Services Administration 

Agency Information Collection 

Activities: Submission for OMB 

Review; Comment Request 

Periodically, the Substance Abuse and 

Mental Health Services Administration 

(SAMHSA) will publish a summary of 

information collection requests under 

OMB review, in compliance with the 

Paperwork Reduction Act (44 U.S.C. 

Chapter 35). To request a copy of these 

documents, call the SAMHSA Reports 

Clearance Officer on (240) 276–1243. 

Project: Program Evaluation for 

Assertive Adolescent & Family 

Treatment (AAFT) Program—NEW 

The Substance Abuse and Mental 

Health Services Administration’s 

(SAMHSA), Center for Substance Abuse 

Services (CSAT) has implemented the 

Assertive Adolescent and Family 

Treatment (AAFT) program to promote 

the adoption of evidence-based 

practices by community providers in the 


srobinson on DSKHWCL6B1PROD with NOTICES
Federal Register / Vol. 76, No. 6 / Monday, January 10, 2011 / Notices 1447 

area of adolescent substance use 

treatment. The AAFT program provides 

evidence-based substance use services 

to adolescents and their families, as well 

as to transition-age youth (TAY), 

caregivers, and their families/mentors. 

This program is based on evidence that 

families/caregivers and other 

appropriate adults are an integral part of 

the treatment process and their 

inclusion in services increases the 

likelihood of successful treatment and 

reintegration of adolescents/TAYs into 

their communities following treatment. 

AAFT requires grantees to implement 

the Adolescent Community 

Reinforcement Approach (A–CRA) 

coupled with Assertive Continuing Care 

(ACC) to provide treatment that is 

context-specific, family-centered, and 

community-based. Grantees are also 

required to use the Global Appraisal of 

Individual Needs (GAIN) as the 

common assessment instrument across 

programs to improve intake assessment, 

clinical interpretation, monitoring, and 

data management. The GAIN is used for 

diagnosis and to assist in placement, 

treatment planning, local evaluation, 

and continuous quality improvement for 

programs. In supporting AAFT and to 

ensure that each implementation 

activity required by AAFT is 

implemented well and as faithfully as 

possible by grantees, CSAT has 

provided, through Chestnut Health 

Systems, a well-thought-out package of 

implementation supports, including 

manual-assisted training in and 

certification for clinical staff on A–CRA 

and ACC, training/certification in GAIN, 

monitoring/coaching/mentoring/support 

for clinicians and supervisors, 

implementation calls and monthly 

progress reports, and topical 

workgroups that share ideas and 

resources among grantees. The 

overarching objective of the multi-site, 

Assertive Adolescent and Family 

Treatment (AAFT) process and outcome 

evaluation is to assess and document 

the process of implementation in the 

2009 cohort of AAFT grantees and to 

explore the role that implementation 

supports play in how well these 

programs evolve. 

CSAT is requesting approval from the 

Office of Management and Budget 

(OMB) to implement a data collection 

document, the Annual Program Survey, 

to gather longitudinal data (end of each 

of 3 project years) from a range of 

grantee personnel to evaluate the 

implementation, expansion, and 

sustainability of adolescent substance 

use services developed under the AAFT 

program. 

The current proposal requests 

implementing the Annual Program 

Survey to collect information in the 

following areas: 

a. Attitudes toward evidence-based 

practices generally, and AAFT model 

components in particular (e.g., attitudes 

toward using a treatment manual, 

achieving certification); 

b. Grantee involvement with the 

implementation supports provided by 

Chestnut Health Systems and their 

reactions to those implementation 

supports; 

c. Perceived changes in clinical 

practice/behavior indicating movement 

toward full A–CRA/ACC 

implementation; 

d. Perceived barriers encountered in 

implementation and compensatory 

strategies; 

e. Report on project progress, 

including activities related to the AAFT 

program, changes to program plans, 

project accomplishments, and efforts to 

plan for sustainability of the program. 

This information would be collected 

annually—in October/November of each 

project year. The survey has three 

versions tailored to address the 

respondents’ roles in the grant 

(Principal Investigator/Program 

Director, Clinical Supervisor/Clinician, 

and Evaluator/Data Manager). Staffing 

patterns at each grantee site vary greatly; 

therefore, CSAT is only able to estimate 

the total number of respondents for each 

category based on initial grantee 

proposals. CSAT expects to conduct 

surveys with approximately 21 

administrators, 56 clinical staff, and 28 

evaluators/data managers. The total 

number of respondents—105 

individuals—represent project staff at 

three distinct levels across 14 grantee 

sites. 

The burden estimate for completing 

the Annual Program Survey is as 

follows: 

ANNUAL REPORTING BURDEN—SUMMARY TABLE

Data 

collection 

activity 

Number 

of 

respondents 1

Responses 

per 

respondent 2

Total 

responses 

Average 

hours per 

response 

Total 

hour 

burden 

Wage rate 

(hourly) 

Total hour cost 

($) 

CY 2010–12 ANNUAL REPORTING BURDEN

AAFT Implementation 

Survey—Principal Investigator/Program 

Director ..................... 21 1 21 0.75 15 .75 50 787 .50 

AAFT Implementation 

Survey—Clinical Supervisor/Clinician ...... 56 1 56 0.75 42 26 1,092 .00 

AAFT Implementation 

Survey—Evaluator/ 

Data Manager ........... 28 1 28 0.75 21 15 315 .00 

Annual Total .......... 105 ........................ 105 ........................ 78 .75 ........................ 2,194 .50 

1 Represents project staff at three distinct levels—administrators, clinical staff, evaluators—across 14 grantee sites. Number of respondents is 

an average of respondents per role based on staffing patterns described in grantee proposals. 2The AAFT Implementation Survey will be completed once by respondents at all 14 sites at the end of each project year. 

Written comments and 

recommendations concerning the 

proposed information collection should 

be sent by February 9, 2011 to: 

SAMHSA Desk Officer, Human 

Resources and Housing Branch, Office 

of Management and Budget, New 

Executive Office Building, Room 10235, 

Washington, DC 20503; due to potential 

delays in OMB’s receipt and processing 

of mail sent through the U.S. Postal 

Service, respondents are encouraged to 

submit comments by fax to: 202–395– 

5806. 


srobinson on DSKHWCL6B1PROD with NOTICES
1448 Federal Register / Vol. 76, No. 6 / Monday, January 10, 2011 / Notices 

Dated: January 3, 2011. 

Elaine Parry, 

Director, Office of Management, Technology 

and Operations. 

[FR Doc. 2011–209 Filed 1–7–11; 8:45 am] 

BILLING CODE 4162–20–P 

DEPARTMENT OF HOMELAND 

SECURITY 

Coast Guard 

[Docket No. USCG–2009–0973] 

Random Drug Testing Rate for 

Covered Crewmembers 

AGENCY: Coast Guard, DHS. 

ACTION: Notice of minimum random 

drug testing rate. 

SUMMARY: The Coast Guard has set the 

calendar year 2011 minimum random 

drug testing rate at 50 percent of 

covered crewmembers. 

DATES: The minimum random drug 

testing rate is effective January 1, 2011 

through December 31, 2011. Marine 

employers must submit their 2010 

Management Information System (MIS) 

reports no later than March 15, 2011. 

ADDRESSES: Annual MIS reports may be 

submitted to Commandant (CG–545), 

U.S. Coast Guard Headquarters, 2100 

Second Street, SW., STOP 7561, 

Washington, DC 20593–7581 or by 

electronic submission to the following 

Internet address: http:// 

homeport.uscg.mil/Drugtestreports. 

FOR FURTHER INFORMATION CONTACT: For 

questions about this notice, please 

contact Mr. Robert C. Schoening, Drug 

and Alcohol Program Manager, Office of 

Investigations and Casualty Analysis 

(CG–545), U.S. Coast Guard 

Headquarters, telephone 202–372–1033. 

If you have questions on viewing or 

submitting material to the docket, call 

Renee V. Wright, Program Manager, 

Docket Operations, telephone 202–366– 

9826. 

SUPPLEMENTARY INFORMATION: Under 46 

CFR 16.230, the Coast Guard requires 

marine employers to establish random 

drug testing programs for covered 

crewmembers on inspected and 

uninspected vessels. 

Every marine employer is required by 

46 CFR 16.500 to collect and maintain 

a record of drug testing program data for 

each calendar year, and submit this data 

by 15 March of the following year to the 

Coast Guard in an annual MIS report. 

Marine employers may either submit 

their own MIS reports or have a 

consortium or other employer 

representative submit the data in a 

consolidated MIS report. 

The purpose of setting a minimum 

random drug testing rate is to assist the 

Coast Guard in analyzing its current 

approach for deterring and detecting 

illegal drug abuse in the maritime 

industry. The testing rate for calendar 

year 2010 was 50 percent. 

The Coast Guard may lower this rate 

if, for two consecutive years, the drug 

test positive rate is less than 1.0 percent, 

in accordance with 46 CFR 16.230(f)(2). 

Since 2009 MIS data indicates that the 

positive rate is greater than one percent 

industry-wide (1.03 percent), the Coast 

Guard announces that the minimum 

random drug testing rate will continue 

at 50 percent of covered employees for 

the period of January 1, 2011 through 

December 31, 2011 in accordance with 

46 CFR 16.230(e). 

Each year, the Coast Guard will 

publish a notice reporting the results of 

random drug testing for the previous 

calendar year’s MIS data and the 

minimum annual percentage rate for 

random drug testing for the next 

calendar year. 

Dated: December 23, 2010. 

Kevin S. Cook, 

Rear Admiral, U.S. Coast Guard, Director of 

Prevention Policy. 

[FR Doc. 2011–170 Filed 1–7–11; 8:45 am] 

BILLING CODE 9110–04–P 

DEPARTMENT OF HOUSING AND 

URBAN DEVELOPMENT 

[Docket No. FR–5480–N–01] 

Notice of Submission of Proposed 

Information Collection to OMB Survey 

of Market Absorption of New 

Multifamily Units 

AGENCY: Office of the Chief Information 

Officer, HUD. 

ACTION: Notice. 

SUMMARY: The proposed information 

collection requirement described below 

has been submitted to the Office of 

Management and Budget (OMB) for 

review, as required by the Paperwork 

Reduction Act. The Department is 

soliciting public comments on the 

subject proposal. 

This survey provides the data 

necessary to measure the rate at which 

different types of new rental apartments 

and new condominium apartments are 

absorbed, that is, taken off the market, 

usually by being rented or sold, over the 

course of the first twelve months 

following completion of a building. The 

data is collected at quarterly intervals 

until the twelve months expire or until 

the units in a building are completely 

absorbed. 

The survey also provides estimates of 

the characteristics of apartments being 

absorbed, and provides a basis for 

analyzing the degree to which 

apartment-building activity is meeting 

the present and future needs of the 

public. Data are collected under Title 

12, U.S.C. Sec. 1701Z–1 and 2. 

DATES: Comments Due Date: February 9, 

2011. 

ADDRESSES: Interested persons are 

invited to submit comments regarding 

this proposal. Comments should refer to 

the proposal by name and/or OMB 

approval Number (2528–0013) and 

should be sent to: HUD Desk Officer, 

Office of Management and Budget, New 

Executive Office Building, Washington, 

DC 20503; fax: 202–395–5806. E-mail: 

OIRA_Submission@omb.eop.gov. 

FOR FURTHER INFORMATION CONTACT: 

Colette Pollard, Reports Management 

Officer, QDAM, Department of Housing 

and Urban Development, 451 Seventh 

Street, SW., Washington, DC 20410; email Colette Pollard at 

Colette.Pollard@hud.gov or telephone 

(202) 402–3400. This is not a toll-free 

number. Copies of available documents 

submitted to OMB may be obtained 

from Ms. Pollard. 

SUPPLEMENTARY INFORMATION: This 

notice informs the public that the 

Department of Housing and Urban 

Development has submitted to OMB a 

request for approval of the Information 

collection described below. This notice 

is soliciting comments from members of 

the public and affecting agencies 

concerning the proposed collection of 

information to: (1) Evaluate whether the 

proposed collection of information is 

necessary for the proper performance of 

the functions of the agency, including 

whether the information will have 

practical utility; (2) Evaluate the 

accuracy of the agency’s estimate of the 

burden of the proposed collection of 

information; (3) Enhance the quality, 

utility, and clarity of the information to 

be collected; and (4) Minimize the 

burden of the collection of information 

on those who are to respond; including 

through the use of appropriate 

automated collection techniques or 

other forms of information technology, 

e.g., permitting electronic submission of 

responses. 

This notice also lists the following 

information: 

Title of Proposal: Survey of Market 

Absorption of New Multifamily Units. 

OMB Approval Number: 2528–0013. 

Form Numbers: H–31. 


srobinson on DSKHWCL6B1PROD with NOTICES